Forecast: Current Health Expenditure in Singapore

In 2023, the current health expenditure in Singapore stood at 4.63 thousand US dollars PPP per capita. This value serves as a baseline for forecasting future expenditures.

From 2024 onward, the projections indicate a steady year-on-year increase in health expenditure. In 2024, the forecasted expenditure rises to 4.74 thousand US dollars PPP per capita, representing a 2.37% increase from 2023. By 2025, the figure is expected to further increase by 2.53% to 4.86 thousand US dollars PPP per capita. Subsequently, it is projected to grow to 4.97 thousand US dollars PPP per capita in 2026, marking a 2.26% uplift, and to 5.08 thousand US dollars PPP per capita in 2027, reflecting a 2.21% rise.

The compound annual growth rate (CAGR) for the period 2023-2027 is approximately 2.34%, indicating a consistent and modest upward trend in health expenditure over this time frame.

Future Trends to Watch For:

Future trends in health expenditure may be influenced by factors such as aging population demographics, advancements in medical technology, inflation in healthcare costs, and potential policy changes. Monitoring these elements will be crucial in understanding and anticipating future expenditure needs and allocations in Singapore’s healthcare sector.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease